ono-4578
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 10, 2017 (NCT03155061)
Timeline
Indications
Mechanism of action
- Prostanoid EP4 receptorANTAGONIST
PTGER4 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ono-4578
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06948448 | Phase 2 | Jul 31, 2025 | Ono Pharmaceuticals |
| NCT06256328 | Phase 2 | Dec 6, 2023 | Ono Pharmaceuticals |
| NCT06570031 | Phase 1 | Nov 9, 2021 | Ono Pharmaceuticals |
| NCT06542731 | Phase 1 | Jun 1, 2021 | Ono Pharmaceuticals |
| NCT06547385 | Phase 1 | Jan 13, 2021 | Ono Pharmaceuticals |
| NCT06538207 | Phase 1 | Jan 13, 2021 | Ono Pharmaceuticals |
| NCT03155061 | Phase 1 | Apr 10, 2017 | Ono Pharmaceuticals |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 7 | 7 | 2 | 2017 |
1 organizations
Page 1 / 1